Phibro Animal Health | PAHC - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Align Technology USD 108.29M 4.48M 2026-06
ANI Pharmaceuticals USD 29.49M 2.86M 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Canopy Growth CAD -157.11M 94.49M 2026-03
Corcept Therapeutics USD 42.14M 73.9M 2026-06
Eli Lilly USD 7.4B 760M 2026-03
Henry Schein USD 107M 6M 2026-03
Idexx Laboratories USD 278.45M 30.26M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Merck USD -4.24B 7.2B 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Pacira USD 2.92M 1.28M 2026-03
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
Zoetis USD 601M 2M 2026-03